Dapagliflozin Reduces Pulmonary Vascular Damage and Susceptibility to Atrial Fibrillation in Right Heart Disease - Concepedia

Concepedia

Publication | Open Access

Dapagliflozin Reduces Pulmonary Vascular Damage and Susceptibility to Atrial Fibrillation in Right Heart Disease

DOI Full Paper Access

18

Citations

36

References

2022

Year

Chang Dai, Bin Kong, Wei Shuai, Zheng Xiao, Tianyou Qin, Jin Fang, Gong Yang, Jun Zhu, Qi Liu, Hui Fu,

ESC Heart Failure

Abstract

Dapagliflozin reduces pulmonary vascular damage and right heart dysfunction, as well as the susceptibility to AF in RHD rats.

References

	Year	Citations

Page 1